Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity

Cell Rep. 2014 Jun 12;7(5):1691-1703. doi: 10.1016/j.celrep.2014.04.046. Epub 2014 May 22.

Abstract

Accumulating evidence has suggested a role for p53 activation in various age-associated conditions. Here, we identified a crucial role of endothelial p53 activation in the regulation of glucose homeostasis. Endothelial expression of p53 was markedly upregulated when mice were fed a high-calorie diet. Disruption of endothelial p53 activation improved dietary inactivation of endothelial nitric oxide synthase that upregulated the expression of peroxisome proliferator-activated receptor-γ coactivator-1α in skeletal muscle, thereby increasing mitochondrial biogenesis and oxygen consumption. Mice with endothelial cell-specific p53 deficiency fed a high-calorie diet showed improvement of insulin sensitivity and less fat accumulation, compared with control littermates. Conversely, upregulation of endothelial p53 caused metabolic abnormalities. These results indicate that inhibition of endothelial p53 could be a novel therapeutic target to block the vicious cycle of cardiovascular and metabolic abnormalities associated with obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diet, High-Fat / adverse effects
  • Human Umbilical Vein Endothelial Cells / metabolism*
  • Humans
  • Insulin Resistance*
  • Lipid Metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mitochondrial Turnover*
  • Muscle, Skeletal / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Obesity / etiology
  • Obesity / metabolism*
  • Oxygen Consumption*
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*
  • Up-Regulation

Substances

  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Ppargc1a protein, mouse
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Nitric Oxide Synthase Type III